CLINICAL AND EXPERIMENTAL DERMATOLOGY, cilt.32, sa.6, ss.733-739, 2007 (SCI-Expanded)
Background. The tumour suppressor gene product, p16, is often inactivated during melanoma malignant progression. Although the importance of p16 in melanomas is well documented, its relationship with cyclin D1, beta-catenin and ultraviolet radiation (UVR) remains unclear.